Inimmune Corporation
Clinical trials sponsored by Inimmune Corporation, explained in plain language.
-
New nasal spray aims to sneeze away ragweed allergies
Symptom relief CompletedThis study tested an experimental nasal spray called INI-2004 in 78 adults with ragweed allergies. Participants received either the spray or a placebo once a week for four weeks. The goal was to see if the spray safely reduces allergy symptoms like sneezing and stuffy nose when e…
Phase: PHASE2 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
New allergy drug shows promise in early human testing
Symptom relief CompletedThis early-stage trial tested a new drug called INI-2004 in 68 healthy volunteers and people with ragweed allergies. The goal was to check safety and how well the body tolerates it, with some early looks at symptom relief. The study is complete, but results are not yet public.
Phase: PHASE1 • Sponsor: Inimmune Corporation • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC